ESC Premium Access

Angioprotein-like 3 and atheroma progression in statin-treated type 2 diabetic patients with coronary artery disease: the pre-specified analysis from the OPTIMAL randomized controlled trial.

Congress Presentation

About the speaker

Doctor Satoshi Kitahara

Kashiwa Kosei General Hospital, Kashiwa (Japan)
0 follower

6 more presentations in this session

Serum lipid profiles and uptake of lipid-lowering therapy in patients with premature atherosclerotic cardiovascular disease (ASCVD) in comparison to older patients with ASCVD

Speaker: Professor T. Tan (Sydney, AU)

Thumbnail

PCSK9 inhibitors in HIV patients with dyslipidemia

Speaker: Doctor S. Datla (Cleveland, US)

Thumbnail

Circulating levels of amyloid-beta (1-40) peptide associate with cardiometabolic traits and risk for metabolic dysfunction-associated steatotic liver disease

Speaker: Doctor E. Aivalioti (Athens, GR)

Thumbnail

The effect of 6-month treatment with coenzyme Q10 on endothelial, vascular and myocardial function in patients with nonalcoholic fatty liver disease.

Speaker: Doctor I. Ikonomidis (Athens, GR)

Thumbnail

The association of steatotic liver disease with recurrent ischemic events in patients with chronic coronary syndrome: a multicenter cohort study

Speaker: Doctor G. Zeng (Beijing, CN)

Thumbnail

Access the full session

Liver metabolism and heart disease

Speakers: Doctor S. Kitahara, Professor T. Tan, Doctor S. Datla, Doctor E. Aivalioti, Doctor I. Ikonomidis...
Thumbnail

About the event

Image

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations